JP4189048B2 - 複素環化合物 - Google Patents

複素環化合物 Download PDF

Info

Publication number
JP4189048B2
JP4189048B2 JP36788797A JP36788797A JP4189048B2 JP 4189048 B2 JP4189048 B2 JP 4189048B2 JP 36788797 A JP36788797 A JP 36788797A JP 36788797 A JP36788797 A JP 36788797A JP 4189048 B2 JP4189048 B2 JP 4189048B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
substituted
alkyl
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP36788797A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11193282A5 (enrdf_load_stackoverflow
JPH11193282A (ja
Inventor
歩 栗本
哲広 荻野
肇 川上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority to JP36788797A priority Critical patent/JP4189048B2/ja
Publication of JPH11193282A publication Critical patent/JPH11193282A/ja
Publication of JPH11193282A5 publication Critical patent/JPH11193282A5/ja
Application granted granted Critical
Publication of JP4189048B2 publication Critical patent/JP4189048B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP36788797A 1997-12-26 1997-12-26 複素環化合物 Expired - Fee Related JP4189048B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Publications (3)

Publication Number Publication Date
JPH11193282A JPH11193282A (ja) 1999-07-21
JPH11193282A5 JPH11193282A5 (enrdf_load_stackoverflow) 2005-09-02
JP4189048B2 true JP4189048B2 (ja) 2008-12-03

Family

ID=18490454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36788797A Expired - Fee Related JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Country Status (1)

Country Link
JP (1) JP4189048B2 (enrdf_load_stackoverflow)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE404561T1 (de) 2001-04-17 2008-08-15 Dainippon Sumitomo Pharma Co Neue adeninderivate
US7754728B2 (en) 2002-09-27 2010-07-13 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound and use thereof
EP1667694B1 (en) * 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
TWI414525B (zh) 2004-03-26 2013-11-11 Dainippon Sumitomo Pharma Co ９-取代-８-氧基腺嘌呤化合物
US20090324551A1 (en) * 2005-08-22 2009-12-31 The Regents Of The University Of California Office Of Technology Transfer Tlr agonists
ES2374455T3 (es) 2006-02-17 2012-02-16 Pfizer Limited Derivados de 3-deazapurinza como moduladores de tlr7.
US8138172B2 (en) 2006-07-05 2012-03-20 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of TLR7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
SI2510946T1 (sl) 2007-02-07 2015-12-31 The Regents Of The University Of California Konjugati sintetičnih agonistov TLR in njihove uporabe
US8063051B2 (en) 2007-03-19 2011-11-22 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
US8067413B2 (en) 2007-03-19 2011-11-29 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
AR065784A1 (es) * 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
ES2393037T3 (es) 2007-05-08 2012-12-18 Astrazeneca Ab Imidazoquinolinas con propiedades inmunomoduladoras
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
CA2711769A1 (en) 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co. Ltd. Method for preparing adenine compound
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
CA2760766A1 (en) 2009-05-21 2010-11-25 Nicholas James Bennett Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
ES2644286T3 (es) 2009-10-22 2017-11-28 Gilead Sciences, Inc. Derivados de purina o deazapurina útiles para el tratamiento de (entre otros) infecciones víricas
EP2563404B1 (en) 2010-04-30 2016-09-21 Urogen Pharma Ltd. Phospholipid drug analogs
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ［４，５−ｃ］キノリン−１−イル誘導体
DK2651943T3 (en) 2010-12-17 2017-06-06 Sumitomo Dainippon Pharma Co Ltd purine derivatives
EP2850067B1 (en) 2012-05-18 2017-08-16 Sumitomo Dainippon Pharma Co., Ltd. Carboxylic acid compounds
RS59435B1 (sr) * 2015-05-08 2019-11-29 Hoffmann La Roche Nova jedinjenja sulfonimidoil purinona i njihovi derivati za lečenje i profilaksu virusne infekcije
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
AU2017320742B2 (en) * 2016-08-29 2021-08-05 F. Hoffmann-La Roche Ag 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
BR112019004560A2 (pt) 2016-09-13 2019-07-02 Hoffmann La Roche tratamento combinado com agonista de tlr7 e um inibidor de formação de capsídeo de hbv
CN111699187A (zh) * 2018-02-12 2020-09-22 豪夫迈·罗氏有限公司 用于治疗和预防病毒感染的新的砜化合物和衍生物
MX2020008746A (es) 2018-02-28 2020-09-28 Hoffmann La Roche Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado.

Also Published As

Publication number Publication date
JPH11193282A (ja) 1999-07-21

Similar Documents

Publication Publication Date Title
JP4189048B2 (ja) 複素環化合物
JP4375901B2 (ja) 新規な複素環化合物
JP4472693B2 (ja) ９置換−８−オキソアデニン化合物
JP4497340B2 (ja) ピリミジン誘導体
JP3315983B2 (ja) １−置換 １Ｈ−イミダゾ（４，５−ｃ）キノリン−４−アミン，中間体及び医薬用組成物
JPH11180981A (ja) 複素環誘導体
RU2127734C1 (ru) Производные пиридопиримидина, их получение, фармацевтическая композиция, способ лечения
KR100338610B1 (ko) 인다졸 유도체 및 포스포디에스터라제 (pde) 유형 iv 및 종양괴사인자 (tnf) 생산의 억제제로서 그의 용도
JPWO2005092892A1 (ja) ８−オキソアデニン化合物
JPH09500376A (ja) Ｐｄｅ−ｉｖ阻害活性を有する新規化合物
JP4342007B2 (ja) キナゾリン誘導体
JP4315300B2 (ja) 新規なキナゾリン誘導体
JPH08502721A (ja) 医薬的に活性な二環式‐複素環アミン
JP2004509855A (ja) ＴＮＦαインヒビターとして有用なクマリン誘導体
US20070179149A1 (en) Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
JP5094725B2 (ja) Ｈｉｖインテグラーゼ阻害剤
JP4248245B2 (ja) ６−フェニルベンゾナフチリジン
JPH11116481A (ja) スタット６活性化阻害剤
JPWO2004002484A1 (ja) ホスホジエステラーゼ阻害剤
JP2000229959A (ja) Ｓｔａｔ６活性化阻害剤
JPH05117273A (ja) 医薬化合物
KR20060092220A (ko) 유도성 ｎｏ-신타아제 저해제로서의 이미다조피리딘 유도체
JPH06503814A (ja) 置換三環式化合物
KR20080014365A (ko) 인터루킨-5 저해효과를 갖는 신규 찰콘계 유도체
JPH1129475A (ja) Ｓｔａｔ６活性化阻害剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041111

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20041111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050210

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20051026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080617

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080618

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080902

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080912

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110919

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees